PubMed for id: 224863

Year	Number of Results
1986	2
1988	2
1989	4
1990	1
1991	3
1992	3
1993	3
1994	3
1995	1
1996	4
1997	6
1998	1
1999	8
2000	3
2001	6
2002	12
2003	7
2004	7
2005	5
2006	4
2007	11
2008	6
2009	13
2010	10
2011	12
2012	9
2013	5
2014	15
2015	14
2016	5
2017	14
2018	8
2019	14
2020	5
2021	8
2022	10
2023	10
2024	4

1

The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome.

Tang F, Wang Y, Wang Y, Jin J, Han W, Chen Y, Yan C, Xu L, Zhang X, Huang X. Tang F, et al. Clin Exp Med. 2024 Feb 8;24(1):33. doi: 10.1007/s10238-023-01287-8. Clin Exp Med. 2024. PMID: 38329593 Free PMC article.

2

[Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].

Xu XS, Ding H, Zhang X, Liao Y, Li H, Liu QY, Liu JZ, Zhang L, Huang J, Gong YP, Ma HB, Xiang B, Dai Y, Hou L, Shuai X, Niu T, Wu Y. Xu XS, et al. Zhonghua Xue Ye Xue Za Zhi. 2023 Sep 14;44(9):742-748. doi: 10.3760/cma.j.issn.0253-2727.2023.09.007. Zhonghua Xue Ye Xue Za Zhi. 2023. PMID: 38049318 Free PMC article. Chinese.

3

Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018.

Morton LM, Curtis RE, Linet MS, Schonfeld SJ, Advani PG, Dalal NH, Sasse EC, Dores GM. Morton LM, et al. EClinicalMedicine. 2023 Jul 5;61:102060. doi: 10.1016/j.eclinm.2023.102060. eCollection 2023 Jul. EClinicalMedicine. 2023. PMID: 37457112 Free PMC article.

4

Relapsed Waldenstrom's Macroglobulinemia and Therapy-Related Myelodysplastic Syndrome with Complex Cytogenetics: A Treatment Dilemma.

Kalantri S, Singh I, Yang L, Abuelgasim KA. Kalantri S, et al. Case Rep Oncol. 2023 May 23;16(1):351-356. doi: 10.1159/000530328. eCollection 2023 Jan-Dec. Case Rep Oncol. 2023. PMID: 37384207 Free PMC article.

5

Allogeneic stem cell transplantation without preconditioning in a child with therapy-related myelodysplastic syndrome: A case report.

Tung YL, Wang YL, Chang TY, Chiu CC, Wen YC, Jaing TH. Tung YL, et al. Medicine (Baltimore). 2023 Feb 10;102(6):e32770. doi: 10.1097/MD.0000000000032770. Medicine (Baltimore). 2023. PMID: 36820588 Free PMC article.

6

Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.

Adkins BD, Mehta A, Selesky M, Vittitow S, Smolkin ME, Ratcliffe SJ, Luckey CJ. Adkins BD, et al. Transfusion. 2022 Dec;62(12):2470-2479. doi: 10.1111/trf.17155. Epub 2022 Oct 24. Transfusion. 2022. PMID: 36278434 Free PMC article.

7

Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis.

Itonaga H, Kida M, Hamamura A, Uchida N, Ozawa Y, Fukuda T, Ueda Y, Kataoka K, Katayama Y, Ota S, Matsuoka KI, Kondo T, Eto T, Kanda J, Ichinohe T, Atsuta Y, Miyazaki Y, Ishiyama K. Itonaga H, et al. Hematol Oncol. 2022 Oct;40(4):752-762. doi: 10.1002/hon.2991. Epub 2022 Apr 5. Hematol Oncol. 2022. PMID: 35299289

8

Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.

Metheny L, Callander NS, Hall AC, Zhang MJ, Bo-Subait K, Wang HL, Agrawal V, Al-Homsi AS, Assal A, Bacher U, Beitinjaneh A, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Cairo M, Cerny J, DeFilipp Z, Perez MAD, Freytes CO, Ganguly S, Grunwald MR, Hashmi S, Hildebrandt GC, Inamoto Y, Kanakry CG, Kharfan-Dabaja MA, Lazarus HM, Lee JW, Nathan S, Nishihori T, Olsson RF, Ringdén O, Rizzieri D, Savani BN, Savoie ML, Seo S, van der Poel M, Verdonck LF, Wagner JL, Yared JA, Hourigan CS, Kebriaei P, Litzow M, Sandmaier BM, Saber W, Weisdorf D, de Lima M. Metheny L, et al. Transplant Cell Ther. 2021 Nov;27(11):923.e1-923.e12. doi: 10.1016/j.jtct.2021.08.010. Epub 2021 Aug 21. Transplant Cell Ther. 2021. PMID: 34428556 Free PMC article.

9

Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts.

Chen Z, Wang SA, Goswami M, Tang G, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. Chen Z, et al. Leuk Res. 2019 Nov;86:106227. doi: 10.1016/j.leukres.2019.106227. Epub 2019 Sep 17. Leuk Res. 2019. PMID: 31557598

10

Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years.

Borate U, Norris BA, Statler A, Fu R, Bucy T, Sekeres MA. Borate U, et al. Blood Adv. 2019 Sep 24;3(18):2738-2747. doi: 10.1182/bloodadvances.2019000293. Blood Adv. 2019. PMID: 31537526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

238 results

Results by year